Enlivex Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 313.63 K | $220.54 K | 99.39% | 1.30% |
| MORGAN STANLEY | 02/13/2026 | 200.63 K | $141.08 K | 15.55% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 195.13 K | $137.21 K | 1,716.98% | 0.81% |
| HRT FINANCIAL LP | 02/12/2026 | 153.99 K | $108.00 K | 719.44% | 0.64% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 85.10 K | $59.82 K | 67,978.40% | 0.35% |
| JANE STREET GROUP, LLC | 02/12/2026 | 74.08 K | $52.10 K | 244.10% | 0.31% |
| XTX TOPCO LTD | 02/17/2026 | 61.80 K | $43.46 K | 44.84% | 0.26% |
| INVESCO LTD. | 02/19/2026 | 60.92 K | $42.84 K | 100.00% | 0.25% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 47.38 K | $33.00 K | 100.00% | 0.20% |
| UBS GROUP AG | 01/29/2026 | 34.99 K | $24.60 K | 766.04% | 0.15% |
| CITADEL ADVISORS LLC | 02/17/2026 | 25.59 K | $17.99 K | -62.88% | 0.11% |
| CITADEL ADVISORS LLC | 02/17/2026 | 24.60 K | $17.30 K | 100.00% | 0.10% |
| PROSPERITY CONSULTING GROUP, LLC | 02/17/2026 | 17.65 K | $12.41 K | 0.00% | 0.07% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 10.99 K | $7.73 K | 0.00% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 10.70 K | $7.52 K | 100.00% | 0.04% |
| SKYVIEW INVESTMENT ADVISORS, LLC | 02/18/2026 | 10.00 K | $7.00 K | 0.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 9.18 K | $6.46 K | 0.00% | 0.04% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 8.88 K | $6.24 K | 100.00% | 0.04% |
| 02/19/2026 | 2.50 K | $1.76 K | 100.00% | 0.01% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 2.24 K | $1.57 K | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 2.14 K | $1.50 K | 0.47% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 2.12 K | $1.49 K | 2,022.00% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 02/13/2026 | 1.02 K | $714 | 0.00% | 0.00% |
| BFSG, LLC | 01/22/2026 | 1.00 K | $704 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/30/2026 | 1.00 K | $703 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 500 | $352 | -80.00% | 0.00% |
| RED TORTOISE LLC | 01/22/2026 | 150 | $105 | 0.00% | 0.00% |
| CITIZENS FINANCIAL GROUP INC/RI | 01/30/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SIGMA INVESTMENT COUNSELORS INC | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SIGNATUREFD, LLC | 01/20/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 01/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enlivex Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd. The most heavily invested institutionals were:
ARK Investment Management LLC: 628,310
UBS Group AG: 138,328
Invesco Ltd.: 61,654
Prosperity Consulting Group, LLC: 17,647
WELLS FARGO & COMPANY/MN: 9,384
Activest Wealth Management: 1,000
5.50% of Enlivex Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 1.99 M shares in the last 24 months. This purchase volume represents approximately $2.30 M in transactions.